Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: Clinical presentation, outcome and pathogenic aspects

Nephrology Dialysis Transplantation

Volumn 22, Issue 5, 2007, Pages 1369-1376

  Terrier, Benjamin ^a   Delmas, Yahsou ^b   Hummel, Aurélie ^a   Presne, Claire ^c   Glowacki, Francois ^d   Knebelmann, Bertrand ^a   Combe, Christian ^b   Lesavre, Philippe ^a   Maillard, Natacha ^a   Noël, Laure Hélène ^a   Patey Mariaud de Serre, Natahlie ^a   Nusbaum, Sylvie ^a   Radford, Isabelle ^a   Buzyn, Agnès ^a   Fakhouri, Fadi ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL PELLEGRIN   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Ciclosporin; Graft vs host disease; Haematopoietic stem cell transplantation; Membranous nephropathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; AZATHIOPRINE; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUDARABINE; IDARUBICIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; FRANCE; GENERAL HOSPITAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOGLOBULIN DEPOSITION; KIDNEY BIOPSY; KIDNEY CELL; KIDNEY FAILURE; MALE; MEDICAL RECORD REVIEW; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROLOGIST; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOLOGIST; PATIENT IDENTIFICATION; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; UNIVERSITY HOSPITAL;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; BIOPSY; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34447521878     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl795     Document Type: Article

References (36)

1. Barbara JA, Thomas, AC, Smith PS, Gillis D, Ho JO, Woodroffe AJ. Membranous nephropathy with graft-vs-host disease in a bone marrow transplant recipient. Clin Nephrol 1992; 37: 115-118
2. Nergizoglu G, Keven K, Ates K et al. Chronic graft-vs-host disease complicated by membranous glomerulonephritis. Nephrol Dial Transplant 1999; 14: 2461-2463
3. Rossi L, Cardarelli F, Vampa ML, Buzio C, Olivetti G. Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma. Nephron 2001; 88: 260-263
4. Oliveira JS, Bahia D, Franco M, Balda C, Stella S. Kerbauy J. Nephrotic syndrome as a clinical manifestation of graft-vs-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant 1999; 23: 99-101
5. Yorioka N, Taniguchi Y, Shimote K et al. Membranous nephropathy with chronic graft-vs-host disease in a bone marrow transplant recipient. Nephron 1998; 80: 371-372
6. Ohsawa I, Ohi H, Fujita T et al. Glomerular and extraglomerular immune complex deposits in a bone marrow transplant recipient. Am J Kidney Dis 2000; 36: E3
7. Sato N, Kishi K, Yagisawa K et al. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-vs-host disease. Bone Marrow Transplant 1995; 16: 303-305
8. Stevenson WS, Nankivell BJ, Hertzberg MS. Nephrotic syndrome after stem cell transplantation. Clin Transplant 2005; 19: 141-144
9. Miyazaki Y, Mori Y, Kishimoto N et al. Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation. Int J Hematol 2003; 78: 262-265
10. Tsutsumi C, Miyazaki Y, Fukushima T et al. Membranous nephropathy after allogeneic stem cell transplantation: Report of 2 cases. Int J Hematol 2004; 79: 193-197
11. Hiesse C, Goldschmidt E, Santelli G, Charpentier B, Machover D, Fries D. Membranous nephropathy in a bone marrow transplant recipient. Am J Kidney Dis 1988; 11: 188-191
12. Lin J, Markowitz GS, Nicolaides M et al. Membranous glomerulopathy associated with graft-vs-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature. Am J Nephrol 2001; 21: 351-356
13. Muller GA, Muller CA, Markovic-Lipkowski J et al. Membranous nephropathy after bone marrow transplantation in ciclosporin treatment. Nephron 1989; 51: 555-556
14. Lee GW, Lee JH, Kim SB et al. Membranous glomerulopathy as a manifestation of chronic graft-vs-host-disease after non-myeloablative stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria. J Korean Med Sci 2003; 18: 901-904
15. Kim KW, Yoon CH, Kay CS et al. Membranous nephropathy after allogeneic hematopoietic stem cell transplantation in a patient with aplastic anemia: A case report. J Korean Med Sci 2003; 18: 287-289
16. Ratanatharathorn V, Ayash L, Reynolds C et al. Treatment of chronic graft-vs-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003; 9: 505-511
17. Srinivasan R, Balow JE, Sabnis S et al. Nephrotic syndrome: An under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation. Br J Haematol 2005; 131: 74-79
18. Bernis C, Camara R, Garcia Sanchez A, Martinez MA, Selgas R. Nephrotic syndrome in a bone marrow transplant recipient after cyclosporine withdrawal. Nephrol Dial Transplant 2003; 18: 2457
19. Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft-vs-host disease: Pathophysiology, clinical manifestations, and management. Cancer 2004, 101: 1936-1946
20. Horwitz ME, Sullivan KM. Chronic graft-vs-host disease. Blood Rev 2006; 20: 15-27
21. Morris SC, Cheek RL, Cohen PL, Eisenberg RA. Autoantibodies in chronic graft vs host result from cognate T-B interactions. J Exp Med 1990; 171: 503-517
22. Bruijn JA, Hogendoorn PC, Corver WE, van den Broek LJ, Hoedemaeker PJ, Fleuren GJ. Pathogenesis of experimental lupus nephritis: A role for anti-basement membrane and antitubular brush border antibodies in murine chronic graft-vs-host disease. Clin Exp Immunol 1990; 79: 115-122
23. Vinzio S, Lioure B, Grunenberger F, Schlienger JL, Goichot B. [Auto-immune-like disease post-bone marrow transplantation]. Rev Med Interne 2004; 25: 514-523
24. Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053-2060
25. Kim BK, Hong HK, Kim JH, Lee HS. Differential expression of nephrin in acquired human proteinuric diseases. Am J Kidney Dis 2002; 40: 964-973
26. Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003; 14: 2958-2966
27. Masuya M, Drake CJ, Fleming PA et al. Hematopoietic origin of glomerular mesangial cells. Blood 2003; 101: 2215-2218
28. Lin F, Cordes K, Li L et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003; 14: 1188-1199
29. Ikarashi K, Li B, Suwa M et al. Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int 2005; 67: 1925-1933
30. Poulsom R, Forbes SJ, Hodivala-Dilke K et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001; 195: 229-235
31. Haas M. IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis 1994; 23: 358-364
32. Ohtani H, Wakui H, Komatsuda A et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 2004; 19: 574-579
33. Cattran DC, Appel GB, Hebert LA et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial. Kidney Int 2001; 59: 1484-1490
34. Cohen CD, Calvaresi N, Armelloni S et al. CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol 2005; 18: 328-333
35. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P. Rituximab for idiopathic membranous nephropathy. Lancet 2002; 360: 923-924
36. Canninga-van Dijk MR, van der Straaten HM, Fijnheer R, Sanders CJ, van den Tweel JG, Verdonck LF. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-vs-host disease. Blood 2004; 104: 2603-2606